Compositions including beta-hydroxy-beta-methylbutyrate
AssigneeAbbott Laboratories
InventorsJeffrey H. Baxter, Anne C. Voss, Pradip Mukerji
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5 ω-3), FOS, carnitine and mixtures thereof. HMB may be added to food products comprising a source of amino-nitrogen enriched with large neutral amino acids such as leucine, isoleucine, valine, tyrosine, threonine and phenylalanine and substantially lacking in free amino acids.
Claims20
A composition comprising:
- a. beta-hydroxy-beta-methylbutyrate, its salts, metabolites or derivatives thereof;
- b. carnitine;
- and
- c. amino nitrogen source enriched with large neutral amino acids;
- wherein the composition is substantially lacking in free amino acids.
Dependencies are inferred from the claim text.